Epigenetic signatures in surrogate tissues are able to assess cancer risk and indicate the efficacy of preventive measures
James E. Barrett(Universität Innsbruck), Martin Widschwendter(University College Hospital)
Cited by 1
Related Papers
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
|Nature Reviews Clinical Oncology|2020|434
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors
|Nature Communications|2017|348
Validation of biomarkers of aging
|Nature Medicine|2024|299
Epigenome-based cancer risk prediction: rationale, opportunities and challenges
|Nature Reviews Clinical Oncology|2018|173
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution
|Nature Communications|2016|74